Skip to content

Effect of Neuromuscular Calf Stimulation and Intermittent Pneumatic Compression on Lower Limb Venous Hemodynamics

Effect of Neuromuscular Calf Stimulation and Intermittent Pneumatic Compression on Lower Limb Venous Hemodynamics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01939288
Enrollment
10
Registered
2013-09-11
Start date
2012-12-31
Completion date
2013-12-31
Last updated
2019-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent Pneumatic Compression

Keywords

neuromuscular stimulation, intermittent pneumatic compression

Brief summary

What is known? * Disorders of peripheral circulation result in vascular morbidity and mortality * Augmentation of peripheral circulation has been shown to be of benefit in both venous and arterial disease * The benefit of intermittent pneumatic compression is clinically well evidenced. * The use of intermittent pneumatic compression is limited by compliance issues related to sleeve application and external power source. What new information will this trial contribute? \- This evaluates the haemodynamic effect of a new electrical device for augmentation of peripheral circulation

Detailed description

RATIONALE - Enhancement of peripheral circulation has been shown to be of benefit in many vascular disorders, and the clinical effectiveness of intermittent pneumatic compression (IPC) is well established in peripheral vascular disease. OBJECTIVE - This study aims to compare the haemodynamic efficacy of a novel neuromuscular electrical stimulation (NMES) device with IPC in healthy subjects. METHODS - 10 healthy volunteers will be randomised into two groups, in an interventional cross-over trial. Baseline measurements of haemodynamic velocity and flow will be taken, then subjects given bilateral therapy with each of the two devices in turn. Laser doppler fluximetry readings will be taken from the hand and foot. Baseline readings will be compared with readings taken after immediate cessation of therapy, and after 10 minutes. Tolerability will be measured using a verbal reported score.

Interventions

DEVICENeuromuscular stimulation, followed by intermittent pneumatic compression
DEVICEIntermittent pneumatic compression, followed by neuromuscular stimulation

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Age \>18 yrs, Body Mass Index (BMI) 17-30Kg/m2

Exclusion criteria

History of heart disease or respiratory disorder, pregnancy, history of peripheral vascular disease or previous thromboembolic event, ABPI\< 0.9, cardiac pacemaker, history of leg fractures and/or presence of metal implants in the leg, long distance travel within one week prior to study

Design outcomes

Primary

MeasureTime frameDescription
IPC(on) Peak Velocity Change From BaselineOne dayUltrasound measurements of peak velocity. This is taken from the left leg superficial femoral vein and artery

Other

MeasureTime frame
NMES(on) Peak Velocity Change From BaselineOne day

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Group 1
Half of recruited subjects (n=5) Neuromuscular stimulator followed by IPC
5
Group 2
Other half of recruited subjects (n=5) IPC followed by neuromuscular stimulator
5
Total10

Baseline characteristics

CharacteristicGroup 1Group 2Total
Age, Continuous27.1 years
STANDARD_DEVIATION 3.8
27.1 years
STANDARD_DEVIATION 3.8
27.1 years
STANDARD_DEVIATION 3.8
Sex: Female, Male
Female
2 Participants2 Participants4 Participants
Sex: Female, Male
Male
3 Participants3 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

IPC(on) Peak Velocity Change From Baseline

Ultrasound measurements of peak velocity. This is taken from the left leg superficial femoral vein and artery

Time frame: One day

ArmMeasureValue (MEDIAN)
Overall SummationIPC(on) Peak Velocity Change From Baseline6.2 cm/s
Other Pre-specified

NMES(on) Peak Velocity Change From Baseline

Time frame: One day

ArmMeasureValue (MEDIAN)
Overall SummationNMES(on) Peak Velocity Change From Baseline36.7 cm/s

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026